Personalised Medicine (PerMed) opens unexplored frontiers to treat diseases at the individual level combining clinical and omics information. However, the performances of the current simu

Aims to lower the barriers for Big Data, IoT, and AI-driven innovation, boosting regulatory compliance, and stimulating additional investment. The project will provide: